# PREOPANC-3 (NCT04927780)

> Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04927780
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Erasmus Medical Center
- Conditions: Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Adenocarcinoma
- Interventions: Leucovorin Calcium; Fluorouracil; Irinotecan Hydrochloride; Oxaliplatin; Resection
- Enrollment: 378
- Primary outcome: Overall survival

## Commentary we found

- X threads: 22
- Podcasts: 8
- YouTube: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=preopanc-3-nct04927780

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04927780", "email": "<work email>"}; the inbox owner confirms by the emailed link.